Understanding the key attributes of CD8 T cell receptor transfer as an antiviral strategy and harnessing the process to combat persistent viral infections

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

We have recently discovered a new process through which the numbers of antiviral immune cells can rapidly expand, without dividing, to combat a virus infection that may otherwise be fatal. This represents a significant advance in our knowledge on how a speedy, virus-specific response can be mounted. We will study how this process can be applied to therapeutic strategies to overcome medically significant persistent viral infections.

Funded Activity Details

Start Date: 01-01-2011

End Date: 01-01-2014

Funding Scheme: Project Grants

Funding Amount: $612,885.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Immunology not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

antiviral immunity | cell-mediated immunity | cytotoxic T lymphocytes (CTL) | immunological intervention | infectious diseases | viral infection | viral persistence